CVS Health Corporation $CVS Shares Sold by Sheets Smith Wealth Management

Posted by Stanley Muller on Jun 22nd, 2026

Sheets Smith Wealth Management reduced its holdings in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 46.0% during the 1st quarter, HoldingsChannel reports. The firm owned 9,211 shares of the pharmacy operator’s stock after selling 7,845 shares during the period. Sheets Smith Wealth Management’s holdings in CVS Health were worth $662,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Caitong International Asset Management Co. Ltd boosted its stake in shares of CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 281 shares during the period. Swiss RE Ltd. acquired a new position in CVS Health in the 4th quarter valued at about $26,000. Sankala Group LLC acquired a new position in CVS Health in the 4th quarter valued at about $28,000. Mcguire Capital Advisors Inc. purchased a new stake in CVS Health during the 4th quarter valued at approximately $28,000. Finally, Ares Financial Consulting LLC acquired a new stake in CVS Health during the 4th quarter worth approximately $29,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at CVS Health

In related news, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the sale, the executive vice president owned 10,133 shares of the company’s stock, valued at approximately $907,714.14. The trade was a 87.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Larry Robbins sold 370,462 shares of the company’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $93.45, for a total transaction of $34,619,673.90. Following the transaction, the director owned 4,824,799 shares in the company, valued at $450,877,466.55. The trade was a 7.13% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 3,441,551 shares of company stock worth $323,703,977 over the last 90 days. Insiders own 0.85% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on CVS shares. Piper Sandler reissued an “overweight” rating and issued a $113.00 target price on shares of CVS Health in a report on Monday, June 1st. Mizuho increased their price target on CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a research report on Thursday, June 11th. UBS Group boosted their price objective on shares of CVS Health from $100.00 to $115.00 and gave the company a “buy” rating in a research note on Monday, June 8th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of CVS Health in a research note on Friday, May 8th. Twenty-two analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $100.68.

Read Our Latest Stock Analysis on CVS

CVS Health Stock Down 0.1%

CVS opened at $98.26 on Monday. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.87 and a quick ratio of 0.66. The business has a 50 day simple moving average of $89.31 and a 200-day simple moving average of $81.50. The stock has a market capitalization of $125.38 billion, a P/E ratio of 43.29, a P/E/G ratio of 0.96 and a beta of 0.62. CVS Health Corporation has a 12 month low of $58.50 and a 12 month high of $102.77.

CVS Health (NYSE:CVS – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share for the quarter, topping analysts’ consensus estimates of $2.21 by $0.36. The firm had revenue of $100.43 billion for the quarter, compared to analyst estimates of $94.99 billion. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.CVS Health’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.25 earnings per share. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, equities analysts anticipate that CVS Health Corporation will post 7.44 earnings per share for the current fiscal year.

CVS Health Profile

(Free Report)

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.